Excellent research, state-of-the-art technology infrastructure, societal embedding of genomics and a stimulating environment for research talent remain key elements of the NGI strategy. The main shift in focus is towards valorisation, i.e., creating added value from genomics research and application gets top priority during the period 2008-2012.

NGI creates societal and economic value from genomics through a network of large-scale Genomics Centres that work on targeted programmes. These centres are consortiums of universities, research institutes, industry and societal organisations.

The Genomics Centres cover the complete chain from basic science to applied research, development and finally valorisation of the results. Societal embedding and creating new economic activity is an integral part of the programme of each consortium.  

Part of Netherlands Genomics Initiative
NMC is part of the national genomics strategy implemented through the Netherlands Genomics Initiative (NGI) and is its Technology Centre of excellence for Metabolomics.

The genomics Centres of Excellence are:

(CBSG)	Centre for BioSystems Genomics
(CMSB)	Centre for Medical Systems Biology
(CGC)	Cancer Genomics Centre
(Kluyver centre)	Kluyver Centre for Genomics of Industrial Fermentation
(CSG)	Centre for Society and Genomics
(NBIC)	Netherlands BioInformatics Centre
(NPC)	Netherlands Proteomics Centre
(CDC)	Celiac Disease Consortium
(Ecogenomics)	Ecogenomics Consortium
(NGC)	Nutrigenomics Consortium
(VIRGO)	VIRGO Consortium
(NTC)	Netherlands Toxicogenomics Centre
(FGCN)	Forensic Genomics Consortium Netherlands
(NCHA)	Netherlands Consortium for Healthy Ageing
(NCSB)	Netherlands Consortium for Systems Biology
(NMC)	Netherlands Metabolomics Centre
(NTC)	Netherlands Toxicogenomics Centre